1. Home
  2. OXY vs RMD Comparison

OXY vs RMD Comparison

Compare OXY & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Occidental Petroleum Corporation

OXY

Occidental Petroleum Corporation

HOLD

Current Price

$39.77

Market Cap

45.0B

Sector

Energy

ML Signal

HOLD

Logo ResMed Inc.

RMD

ResMed Inc.

HOLD

Current Price

$245.15

Market Cap

36.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OXY
RMD
Founded
1920
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
45.0B
36.4B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
OXY
RMD
Price
$39.77
$245.15
Analyst Decision
Hold
Buy
Analyst Count
22
13
Target Price
$49.73
$289.09
AVG Volume (30 Days)
8.5M
924.4K
Earning Date
11-10-2025
01-29-2026
Dividend Yield
2.41%
0.98%
EPS Growth
N/A
29.59
EPS
1.39
9.77
Revenue
$26,601,000,000.00
$5,257,400,000.00
Revenue This Year
N/A
$9.85
Revenue Next Year
N/A
$7.36
P/E Ratio
$28.66
$25.05
Revenue Growth
N/A
9.36
52 Week Low
$34.79
$199.92
52 Week High
$53.20
$293.81

Technical Indicators

Market Signals
Indicator
OXY
RMD
Relative Strength Index (RSI) 41.36 43.12
Support Level $39.72 $241.66
Resistance Level $40.47 $247.45
Average True Range (ATR) 0.82 4.94
MACD -0.09 -0.28
Stochastic Oscillator 29.91 18.66

Price Performance

Historical Comparison
OXY
RMD

About OXY Occidental Petroleum Corporation

Occidental Petroleum is an independent exploration and production company with operations in the United States, Latin America, and the Middle East. At the end of 2023, the company reported net proved reserves of nearly 4 billion barrels of oil equivalent. Net production averaged 1,327 thousand barrels of oil equivalent per day in 2024 at a ratio of roughly 52% oil and natural gas liquids and 48% natural gas.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Share on Social Networks: